Zobrazeno 1 - 10
of 18
pro vyhledávání: '"35"'
Publikováno v:
Gut. 53:1117-1122
Background: Anti- Saccharomyces cerevisiae antibodies (ASCA) are a specific but only moderately sensitive diagnostic marker for Crohn’s disease. We sought to explore the role of ASCA as a prognostic marker for aggressive disease phenotype in Crohn
Autor:
Henrik Toft Sørensen, Thomas A. Ullman, David T. Rubin, Robert S. Sandler, Michael D. Kappelman, Lars Pedersen, John A. Baron, Erzsébet Horváth-Puhó
Publikováno v:
Kappelman, M D, Horváth-Puhó, E, Sandler, R S, Rubin, D T, Ullman, T A, Pedersen, L, Baron, J A & Sørensen, H T 2011, ' Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study ', Gut, vol. 60, pp. 937-43 . https://doi.org/10.1136/gut.2010.228585
Background Recommendations for venous thromboembolism (VTE) prophylaxis in patients with inflammatory bowel disease (IBD) can be refined by incorporating patient-specific risk factors. Objectives To determine the risk of deep venous thrombosis (DVT)
Autor:
Jan Wohlfahrt, Ebbe Langholz, Saima Basit, Mikael Andersson, Tine Jess, Christine Rungoe, Nete Munk Nielsen
Publikováno v:
Gut. 63(10)
Treatment possibilities have changed in inflammatory bowel disease (IBD). We assessed changes in medical treatment and surgery over time and impact of medications on risk of surgery in a population-based cohort.48 967 individuals were diagnosed with
Autor:
Russell Foster, A Roseth, G Sigthorsson, Magne K. Fagerhol, J A Tibble, K Teahon, B Thjodleifsson, R Sherwood, Ingvar Bjarnason, S Bridger
Publikováno v:
Gut. 47:506-513
BACKGROUND AND AIMS—Assessing the presence and degree of intestinal inflammation objectively, simply, and reliably is a significant problem in gastroenterology. We assessed faecal excretion of calprotectin, a stable neutrophil specific marker, as a
Autor:
D M Richards, M H Irving
Publikováno v:
Gut. 40:218-222
BACKGROUND: A study was performed to measure the quality of life of patients receiving home parenteral nutrition (HPN). Quality of life is an important determinant of the effectiveness of health technologies, but it has rarely been assessed in patien
Publikováno v:
Gut. 38:733-737
BACKGROUND--Thrombosis may be an important effector mechanism in the pathogenesis of Crohn's disease. METHODS--This study therefore investigated the prevalence of independent thrombotic risk factors (factor VII coagulant activity, lipoprotein (a), fi
Publikováno v:
Gut. 38:538-542
BACKGROUND--Ulcerative colitis is the only known inflammatory bowel disease associated with particular HLA alleles. Whereas the association with the HLA-DRB1*15 allele has been described in several independent studies for ulcerative colitis, no contr
Publikováno v:
Gut. 35:1070-1075
Between 1976 and 1985, 110 patients had restorative proctocolectomy or proctectomy for ulcerative colitis and 103 were followed up until death or February 1992. There was one postoperative and one late death related to surgery. The cumulative probabi
Publikováno v:
Gut. 34:1547-1551
The family history of patients identified during incidence studies in Leicestershire were investigated and the prevalence and comparative risks calculated; 1254 patients aged 15 to 80 years were sent a questionnaire about their family history. All ca
Autor:
Laurent Peyrin-Biroulet, Marc-André Bigard, Aude Bressenot, Abderrahim Oussalah, O. Bruot, Denis Régent, Valérie Laurent
Publikováno v:
Gut. 59(8)
Magnetic resonance imaging (MRI) enables accurate assessment of inflammatory bowel diseases (IBD), but its main limitation is the need for bowel preparation. Diffusion-weighted imaging is feasible in Crohn's disease. We evaluated the accuracy of MRI